StoryFunding
Isomorphic Labs raises $2.1B Series B led by Thrive Capital, largest AI-drug-discovery round to date
Isomorphic Labs announced a $2.1B Series B funding round led by Thrive Capital, with participation from Alphabet, GV, MGX (Abu Dhabi), Temasek, CapitalG and the UK Sovereign AI Fund. The round brings total capital raised to approximately $2.6B and funds the push to advance the first AI-designed drug candidates into human trials by end of 2026.